Mitsubishi Corporation (“MC”) will strengthen its medical device import and distribution business by expanding its product offerings for medical institutions. As part of this strategy, Mitsubishi Corporation has agreed today with Kobayashi Pharmaceutical to acquire 80% of Kobayashi Medical, a wholly-owned subsidiary of Kobayashi Pharmaceutical.
With the aging of society, companies involved in the medical field are increasingly seeking to offer safe medical devices to treat lifestyle diseases such as cancer as well as myocardial infarction, strokes, and bone fractures.
MC is involved in the import and distribution of medical devices through its group company, which mainly handles endoscopes and surgical instruments in minimally invasive surgery and urology.
Teaming up with Kobayashi Medical, which handles bone fracture treatment equipment and surgical instruments, will enable MC to offer a wider range of devices and products. In addition, MC is aiming to expand Kobayashi Medical’s business by leveraging MC’s global network and partnerships with its group companies.
Through the medical field business, Mitsubishi Corporation is working to create sustainable corporate value by contributing to economic and social development.
source : http://www.mitsubishicorp.com/jp/en/pr/archive/2012/html/0000014586.html